China GLP-1 Receptor Agonist Market Analysis and Trends China represents a major emerging market, driven by an increasing diabetes burden, expanding healthcare access, and supportive government initiatives
4 (download XLSX Statistical source data for Fig
Changes in body composition may alter adipose tissue-derived hormones, which have complex interactions with mood-regulating brain circuits, though research in this area is still evolving
To view or add a comment, sign in More Relevant Posts GLP-1 Drugs: The Legend, Myth and the Magic From Evolutionary Biology to Evidence-Based Obesity Care At GoDocta and Urgent Care SKN, we approach weight loss the way medicine should be practiced: Care you can trust Led by real clinicians Backed by science Obesity is not a failure of willpower
While not a medical diagnosis, it highlights the potential side effect of rapid fat loss in the face, leading to visible changes like sunken cheeks and looser skin